D. E. Shaw & Co., Inc. Abbott Laboratories Put Options Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

Put Options

19 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $6.66 Million - $7.43 Million	66,100 Added 303.21%	87,900 $9.13 Million
Q1 2024 May 15, 2024	SELL	$109.52 - $120.96 $6.74 Million - $7.44 Million	-61,500 Reduced 73.83%	21,800 $2.48 Million
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $3.23 Million - $3.95 Million	-35,800 Reduced 30.06%	83,300 $9.17 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $2.3 Million - $2.76 Million	24,100 Added 25.37%	119,100 $11.5 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $3.53 Million - $3.93 Million	35,000 Added 58.33%	95,000 $10.4 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $3.58 Million - $4.22 Million	-37,000 Reduced 38.14%	60,000 $6.08 Million
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $2.57 Million - $3.01 Million	-27,000 Reduced 21.77%	97,000 $10.7 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $9.1 Million - $10.5 Million	94,000 Added 313.33%	124,000 $12 Million
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $38.2 Million - $46.2 Million	-374,700 Reduced 92.59%	30,000 $3.26 Million
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $38 Million - $46.3 Million	332,900 Added 463.65%	404,700 $47.9 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $7.14 Million - $8.74 Million	61,800 Added 618.0%	71,800 $10.1 Million
Q3 2020 Nov 16, 2020	SELL	$91.64 - $111.29 $1.01 Million - $1.22 Million	-11,000 Reduced 52.38%	10,000 $1.09 Million
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $6.32 Million - $7.04 Million	-80,500 Reduced 79.31%	21,000 $1.82 Million
Q3 2019 Nov 14, 2019	BUY	$81.84 - $88.74 $3.6 Million - $3.9 Million	44,000 Added 76.52%	101,500 $8.49 Million
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $3.51 Million - $4.23 Million	-57,700 Reduced 50.09%	57,500 $4.22 Million
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $7.24 Million - $7.99 Million	-125,800 Reduced 52.2%	115,200 $7.03 Million
Q1 2018 May 15, 2018	SELL	$56.27 - $63.62 $4.34 Million - $4.91 Million	-77,200 Reduced 24.26%	241,000 $14.4 Million
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $9.29 Million - $9.95 Million	173,100 Added 119.3%	318,200 $18.2 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $6.97 Million - $7.78 Million	145,100	145,100 $7.74 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$19.2 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$8.76 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.51 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.09 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account